UFC welterweight draws two-year suspension following USADA violation

Ultimate Fighting Championship (UFC) will no longer have access to veteran welterweight Viscardi Andrade, who flunked his out-of-competition drug test issued by United States Anti-Doping Agency (USADA).

Andrade (19-6) was last seen capturing a unanimous decision win over Rchard Walsh at the UFC Fight Night 85 mixed martial arts (MMA) event in Brisbane, Australia, back in March 2016.

From the official USADA release:

“Andrade, 33, tested positive for stanozolol and its metabolites, 16β‐hydroxy‐stanozolol and 3’‐hydroxy‐stanozolol, following an out-of-competition urine test conducted on March 7, 2016. Stanozolol is a non-Specified Substance in the category of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.

“Andrade’s two-year period of ineligibility began on March 20, 2016, the day after his most recent bout, a victory, at the UFC Fight Night event in Brisbane, Australia, on March 19, 2016. Per the UFC Anti-Doping Policy, an Anti-Doping Policy Violation occurring during, or in connection with, a bout may, upon the decision of UFC, lead to disqualification of all the athlete’s results obtained in that bout. Here, because Andrade’s violation resulted from a sample collection that occurred prior to his bout, all information surrounding Andrade’s positive test and sanction has been provided to UFC to make the determination concerning his competition results.”

Andrade’s win will be overturned to a No Contest, according to a statement provided to MMA Fighting, and the Brazilian will be fined an “amount to be determined” to offset the costs of the Anti-Doping Program.